PRGO: Perrigo Company plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,913.63
Enterprise Value ($M) 6,972.93
Book Value ($M) 4,319.40
Book Value / Share 31.65
Price / Book 0.91
NCAV ($M) -2,846.40
NCAV / Share -20.86
Price / NCAV -1.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.04

Liquidity (mrq)
Quick Ratio 1.34
Current Ratio 2.38

Balance Sheet (mrq) ($M)
Current Assets 2,481.90
Assets 9,647.70
Liabilities 5,328.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4,373.40
Operating Income 314.60
Net Income -171.80
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 362.90
Cash from Investing 78.80
Cash from Financing -611.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Price T Rowe Associates Inc /md/ 5.80 9,919.21
02-06 13G State Street Corp 5.10
10-31 13G Dimensional Fund Advisors Lp 5.10
2024-02-13 13G Barrow Hanley Mewhinney & Strauss Llc
2024-02-13 13G/A Vanguard Group Inc 11.07 2.77

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 208,951 1,418,674 14.73
2025-03-06 307,235 1,883,513 16.31
2025-03-05 210,554 1,152,475 18.27
2025-03-04 527,012 2,707,465 19.47

(click for more detail)

Similar Companies
OGN – Organon & Co. PBH – Prestige Consumer Healthcare Inc.
PFE – Pfizer Inc. QGEN – Qiagen N.V.
RCUS – Arcus Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io